• Molecular NameSilodosin
  • SynonymKMD-3213
  • Weight495.542
  • Drugbank_IDDB06207
  • ACS_NO160970-54-7
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)2.29
  • pkaN/A
  • LogD (pH=7, predicted)-0.2
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.91
  • LogSw (predicted, AB/LogsW2.0)0.16
  • Sw (mg/ml) (predicted, ACD/Labs)0.11
  • No.of HBond Donors4
  • No.of HBond Acceptors7
  • No.of Rotatable Bonds14
  • TPSA97.05
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn α1-adrenoceptor antagonist with high uroselectivity.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability32.0
  • Protein binding97.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic glucuronidation (UGT2B7-mediated); also minor CYP3A4 involvement
  • Half life13 h
  • ExcretionRenal and fecal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A